Combined-modality therapy for primary central nervous system lymphoma: Long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group)-Reference-Cited by-同舟云学术

Combined-modality therapy for primary central nervous system lymphoma: Long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group)

Published:2006-02 Issue:2 Volume:64 Page:408-413
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

O’Brien Peter C.,Roos Daniel E.,Pratt Gary,Liew K.-H.,Barton Michael B.,Poulsen Michael G.,Olver Ian N.,Trotter Grant E.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference28 articles.

1. Long-term survival in primary CNS lymphoma;Abrey;J Clin Oncol,1998

2. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma;Poortmans;J Clin Oncol,2004

3. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas;Schultz;J Clin Oncol,1996

4. Primary central nervous system non-Hodgkin’s lymphoma;O’Neill;Int J Radiat Oncol Biol Phys,1995

5. A Medical Research Council randomized trial in patients with primary cerebral non-Hodgkin lymphoma;Mead;Cancer,2000

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thiotepa, Busulfan, Cyclophosphamide: Effective but Toxic Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Central Nervous System Lymphoma;Medical Sciences;2023-01-29

2. Case report and review of the literature of primary central nervous system lymphoma of the fourth ventricle;Surgical Neurology International;2022-11-11

3. Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C;Neuro-Oncology;2022-11-05

4. Experience With Tirabrutinib in the Treatment of Primary Central Nervous System Lymphoma that Is Difficult to Treat With Standard Treatment;Anticancer Research;2022-07-26

5. Efficacy and toxicity with radiation field designs and concurrent temozolomide for CNS lymphoma;Neuro-Oncology Practice;2022-06-22